高龄非ST段抬高型心肌梗死患者二尖瓣反流与预后
基于LONGEVO-SCA前瞻性注册研究,纳入532例年龄≥80岁的NSTEMI患者,497例住院期间超声心动图定量二尖瓣反流(MR)。108例(21.7%)存在显著MR,其基线临床状态更差,院内死亡率更高(4.6% vs 1.3%,p=0.04),6个月死亡/再入院风险升高(HR 1.54,95%CI 1.09-2.18,p=0.015),但校正混杂因素后该关联不显著。
要点
- 高龄NSTEMI患者中约五分之一存在显著二尖瓣反流。
- 显著MR者基线衰弱、失能、营养不良风险更高,心功能更差。
- 显著MR与6个月死亡/再入院风险升高相关,但校正后不显著。
核心结论
- 显著二尖瓣反流在高龄NSTEMI患者中常见,其不良预后主要由基线临床特征决定。
研究设计与样本
- 多中心前瞻性注册研究LONGEVO-SCA纳入532例年龄≥80岁的非ST段抬高型心肌梗死患者,其中497例住院期间行超声心动图定量二尖瓣反流。
主要发现
- 108例(21.7%)存在显著二尖瓣反流(中度或重度)。
- 显著MR组较无显著MR组年龄更大,衰弱、失能、营养不良风险更高,收缩压更低、心率更高、Killip分级更差、左心室射血分数更低、肺动脉压更高,新发心房颤动更多(所有p值=0.001)。
- 显著MR组院内死亡率更高(4.6% vs 1.3%,p=0.04),住院时间更长(中位数8[5-12]天 vs 6[4-10]天,p=0.002)。
- 显著MR组6个月死亡/再入院风险升高(HR 1.54,95%CI 1.09-2.18,p=0.015),但校正潜在混杂因素后该关联不显著。
临床怎么用
- 对高龄NSTEMI患者应关注二尖瓣反流评估,并将其纳入整体老年综合评估以识别高危患者。
局限性
- 显著MR与6个月不良结局的关联在校正混杂因素后不显著,提示预后主要由基线临床特征驱动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJETCTIVES: Mitral regurgitation (MR)after an acute coronary syndrome is associated with a poor prognosis. However,the prognostic impact of MR in elderly patients with non-ST-segment elevation myocardialinfarction (NSTEMI) has not been well addressed. DESIGN: Prospective registry. SETTING AND PARTICIPANTS: The multicenter LONGEVO-SCA prospective registry included 532 unselected NSTEMI patients aged ≥80 years. MEASUREMENTS: MR was quantified using echocardiography during admission in 497 patients. They were classified in two groups: significant (moderate or severe) or not significant MR (absent or mild). We evaluated the impact of MR status on mortality or readmission at 6 months. RESULTS: Mean age was 84.3±4.1 years, and 308 (61.9%) were males. A total of 108 patients (21.7%) had significant MR. Compared with those without significant MR, they were older and showed worse baseline clinical status, with higher frailty, disability, and risk of malnutrition. They also had lower systolic blood pressure, higher heart rate, worse Killip class, lower left ventricular ejection fraction, and higher pulmonary pressure on admission, as well as more often new onset atrial fibrillation (all p values = 0.001). Patients with significant MR also had higher in-hospital mortality (4.6% vs. 1.3%, p = 0.04), longer hospital stay (median 8 [5-12] vs. 6 [4-10] days, p = 0.002), and higher mortality/readmission at 6 months (hazard ratio 1.54, 95% confidence interval 1.09-2.18, p = 0.015). However, after adjusting for potential confounders, this last association was not significant. CONCLUSIONS: Significant MR is seen in one fifth of octogenarians with NSTEMI. Patients with significant MR have a poor prognosis, mainly determined by their baseline clinical characteristics. J Am Geriatr Soc 67:1641-1648, 2019.
引用
- Díez-Villanueva P, Vera A, Ariza-Solé A, et al. Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients. J Am Geriatr Soc. 2019. PMID: 31045252. doi:10.1111/jgs.15926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。